Showing results (211-220 of 257) with videos related to
Sort By:
Pageof 26
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 28, 2002
Histopathologic features of genetically determined ovarian cancerP A Shaw, J R McLaughlin, R P Zweemer, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 2, 2007
Orthostatic hypotension and attention in Parkinson's disease with and without dementiaC Peralta, M Stampfer-Kountchev, E Karner, et al.Cancer Letters|January 15, 1993
The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-alpha treatmentC D Richters, C W Burger, A A van de Loosdrecht, et al.The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal womenV Mijatovic, P Kenemans, J C Netelenbos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucinS von Mensdorff-Pouilly, A A Verstraeten, P Kenemans, et al.Nuclear Medicine Communications|July 1, 1991
Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancerL F Massuger, R A Claessens, P Kenemans, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 27, 2000
Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1K Ryuko, D J Schol, F G Snijdewint, et al.Histopathology|June 26, 2003
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predispositionJ M J Piek, R H M Verheijen, F H Menko, et al.Maturitas|April 2, 1998
Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnoverG W de Valk-de Roo, J C Netelenbos, I R Peters-Muller, et al.Cancer Causes & Control : CCC|July 6, 2000
Weight change and risk of postmenopausal breast cancer (United States)A Trentham-Dietz, P A Newcomb, K M Egan, et al.Pageof 26